| pubmed-article:6687399 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:6687399 | lifeskim:mentions | umls-concept:C0858252 | lld:lifeskim |
| pubmed-article:6687399 | lifeskim:mentions | umls-concept:C0009429 | lld:lifeskim |
| pubmed-article:6687399 | lifeskim:mentions | umls-concept:C0441771 | lld:lifeskim |
| pubmed-article:6687399 | pubmed:issue | 1 | lld:pubmed |
| pubmed-article:6687399 | pubmed:dateCreated | 1983-3-11 | lld:pubmed |
| pubmed-article:6687399 | pubmed:abstractText | The results of a pilot multimodality program (surgery + radiotherapy + chemotherapy) are reported in 34 women with advanced stage III and IV adenocarcinoma of the breast. The median relapse-free survival for all patients was 24 months, with 74% of the premenopausal patients and 37% of the postmenopausal alive at five years (P = 0.18). The relapse rate was significantly lower in premenopausal patients when compared to the postmenopausal subgroup. Estrogen receptor status was not predictive for relapse or survival. | lld:pubmed |
| pubmed-article:6687399 | pubmed:language | eng | lld:pubmed |
| pubmed-article:6687399 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6687399 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:6687399 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6687399 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6687399 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6687399 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:6687399 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:6687399 | pubmed:month | Jan | lld:pubmed |
| pubmed-article:6687399 | pubmed:issn | 0022-4790 | lld:pubmed |
| pubmed-article:6687399 | pubmed:author | pubmed-author:MichelAA | lld:pubmed |
| pubmed-article:6687399 | pubmed:author | pubmed-author:ShapiroC MCM | lld:pubmed |
| pubmed-article:6687399 | pubmed:author | pubmed-author:DesserR KRK | lld:pubmed |
| pubmed-article:6687399 | pubmed:author | pubmed-author:RecantWW | lld:pubmed |
| pubmed-article:6687399 | pubmed:author | pubmed-author:RochmanHH | lld:pubmed |
| pubmed-article:6687399 | pubmed:author | pubmed-author:BitranJ DJD | lld:pubmed |
| pubmed-article:6687399 | pubmed:author | pubmed-author:RobinEE | lld:pubmed |
| pubmed-article:6687399 | pubmed:author | pubmed-author:BillingsA AAA | lld:pubmed |
| pubmed-article:6687399 | pubmed:author | pubmed-author:KozloffM FMF | lld:pubmed |
| pubmed-article:6687399 | pubmed:author | pubmed-author:SchifelingDD | lld:pubmed |
| pubmed-article:6687399 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:6687399 | pubmed:volume | 22 | lld:pubmed |
| pubmed-article:6687399 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:6687399 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:6687399 | pubmed:pagination | 5-8 | lld:pubmed |
| pubmed-article:6687399 | pubmed:dateRevised | 2006-4-24 | lld:pubmed |
| pubmed-article:6687399 | pubmed:meshHeading | pubmed-meshheading:6687399-... | lld:pubmed |
| pubmed-article:6687399 | pubmed:meshHeading | pubmed-meshheading:6687399-... | lld:pubmed |
| pubmed-article:6687399 | pubmed:meshHeading | pubmed-meshheading:6687399-... | lld:pubmed |
| pubmed-article:6687399 | pubmed:meshHeading | pubmed-meshheading:6687399-... | lld:pubmed |
| pubmed-article:6687399 | pubmed:meshHeading | pubmed-meshheading:6687399-... | lld:pubmed |
| pubmed-article:6687399 | pubmed:meshHeading | pubmed-meshheading:6687399-... | lld:pubmed |
| pubmed-article:6687399 | pubmed:meshHeading | pubmed-meshheading:6687399-... | lld:pubmed |
| pubmed-article:6687399 | pubmed:meshHeading | pubmed-meshheading:6687399-... | lld:pubmed |
| pubmed-article:6687399 | pubmed:meshHeading | pubmed-meshheading:6687399-... | lld:pubmed |
| pubmed-article:6687399 | pubmed:meshHeading | pubmed-meshheading:6687399-... | lld:pubmed |
| pubmed-article:6687399 | pubmed:meshHeading | pubmed-meshheading:6687399-... | lld:pubmed |
| pubmed-article:6687399 | pubmed:meshHeading | pubmed-meshheading:6687399-... | lld:pubmed |
| pubmed-article:6687399 | pubmed:meshHeading | pubmed-meshheading:6687399-... | lld:pubmed |
| pubmed-article:6687399 | pubmed:meshHeading | pubmed-meshheading:6687399-... | lld:pubmed |
| pubmed-article:6687399 | pubmed:meshHeading | pubmed-meshheading:6687399-... | lld:pubmed |
| pubmed-article:6687399 | pubmed:meshHeading | pubmed-meshheading:6687399-... | lld:pubmed |
| pubmed-article:6687399 | pubmed:meshHeading | pubmed-meshheading:6687399-... | lld:pubmed |
| pubmed-article:6687399 | pubmed:meshHeading | pubmed-meshheading:6687399-... | lld:pubmed |
| pubmed-article:6687399 | pubmed:meshHeading | pubmed-meshheading:6687399-... | lld:pubmed |
| pubmed-article:6687399 | pubmed:year | 1983 | lld:pubmed |
| pubmed-article:6687399 | pubmed:articleTitle | Multimodality therapy of stage III adenocarcinoma of the breast. | lld:pubmed |
| pubmed-article:6687399 | pubmed:publicationType | Journal Article | lld:pubmed |
